Aura Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Aura Biosciences

09/08/2023 13:59

* Aura Biosciences Inc  AURA.OQ  reported a quarterly
adjusted
loss of 48 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 49 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aura Biosciences Inc's reported EPS for the quarter was a
loss
of 48 cents​.
    * The mean earnings estimate of analysts had risen by
about 13.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Aura Biosciences Inc shares had fallen by 4.5% this
quarter and
gained 12.3% so far this year.
    * The company reported a quarterly loss of $18.3 million.
    * Wall Street's median 12-month price target for Aura
Biosciences
Inc is $27.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 12:59 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.49          -0.48          Beat
 Mar. 31 2023      -0.54          -0.46          Beat
 Dec. 31 2022      -0.52          -0.55          Missed
 Sep. 30 2022      -0.51          -0.54          Missed